COSCIENS Biopharma Inc. has seen remarkable price movements recently, with a notable surge this week.
COSCIENS Biopharma Inc. (CSCI.TO) has experienced significant price action, climbing 4.94% today and an impressive 131.61% over the past week. This surge comes amid ongoing developments in the company, particularly regarding its share capital structure.
Investor takeaway: Investors should remain cautious despite recent gains, given the company's volatility and the lack of major news that could sustain this upward momentum.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
COSCIENS Biopharma Inc.
CSCI.TO
CSCI.TO
COSCIENS Biopharma Inc.
WealthAwesomeMarket cap
$7.07M
52W high
$14.80
52W low
$1.10
1W change
-7.79%
Beta
1.90
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
575.0%
Annualized
90-Day Vol
353.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$8.49
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.54 | C$1.04 – C$54.79 |
| 60 trading days | C$8.00 | C$0.48 – C$132.28 |
| 90 trading days | C$8.49 | C$0.27 – C$263.75 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
COSCIENS Biopharma Inc. Stock Up 131.61% This Week.
The stock has seen a substantial increase in value, reflecting both speculative trading and potential investor optimism.
Bull case
Positive sentiment around COSCIENS may stem from its recent financial results and anticipated developments in its business strategy. Investors are likely encouraged by the company's performance and future prospects, which could lead to continued interest.
Bear case
However, the company's high beta of 1.90 indicates significant volatility. This means the stock could experience sharp declines if market sentiment shifts negatively, making it a risky investment for those who prefer stability.
Recent Price Action
Advertisement
COSCIENS Biopharma Inc. has closed at C$8.49, reflecting a daily increase of 4.94%. Over the past week, the stock has surged by 131.61%, and it has seen a remarkable rise of 197.20% in the last month. Year-to-date, the stock is up 193.10%, indicating strong momentum.
Company News and Catalysts
Currently, there are no major announcements from COSCIENS Biopharma Inc. that could explain the recent price movements. However, the company has been in the news for its share capital amendment, which involves a consolidation of shares followed by a split. This restructuring may have contributed to increased trading activity and investor interest.
Technical Picture
From a technical standpoint, COSCIENS Biopharma Inc. is trading significantly below its moving averages, with a 50-day moving average of C$23.30 and a 200-day moving average of C$25.00, representing declines of 63.6% and 66.0%, respectively. The stock has a beta of 1.90, indicating a higher level of volatility compared to the broader market. The current price is 54% of its 52-week range, which spans from C$1.10 to C$14.80. Recent trading volume has been around 519 shares, compared to a 20-day average of 2,748 shares, reflecting 1.50 times the average volume.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
